Theravance Biopharma, Inc. Announces Strategic Actions and Reports Fourth Quarter / Full Year 2022 Financial Results and Business Update

Go back to Theravance Biopharma, Inc. Announces Strategic Actions and Reports Fourth Quarter / Full Year 2022 Financial Results and Business Update
(NASDAQ: TBPH) Delayed: 17.27 +0.30 (1.77%)
Previous Close $16.97    52 Week High $38.92 
Open $17.07    52 Week Low $12.87 
Day High $17.67    P/E N/A 
Day Low $17.07    EPS $0.00 
Volume 716,399